Assembly Biosciences
ASMB26.5350.36% ( +0.095 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Assembly Biosciences(ASMB) predict that the Revenue is 8.213 M (-12.8%), Beat estimate;the EBIT is -11.37 M (-14.37%), Miss estimate;the EPS is -0.54 (+53.85%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B12.80%
0.01B26.22%
+0.00B13.42%
EBITMiss expectations
-0.01B14.37%
-0.01B9.76%
-0.00B4.61%
EPSExceed expectations
-0.5453.85%
-0.5751.28%
+0.03002.57%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf